Pew Research Center conducted this study to understand Americans’ views of the coronavirus and COVID-19 vaccines. For this analysis, we surveyed 10,133 U.S. adults from Feb. 7 to 11, 2024. Everyone ...
Amid the declining clinical severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and diminishing public uptake of annual coronavirus disease 2019 (Covid-19) vaccines, ...
Since May, highly contagious "FLiRT" coronavirus variants – a term for new mutations of Omicron – have been driving a rise in infections and emergency room trips. Virus levels at local wastewater ...
Nirmatrelvir in combination with ritonavir is an antiviral treatment for mild-to-moderate coronavirus disease 2019 (Covid-19). The efficacy of this treatment in patients who are at standard risk for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results